Literature DB >> 23843034

Epidemiology and clinical features of systemic vasculitis.

David G I Scott1, Richard A Watts2.   

Abstract

Different vasculitic syndromes present in different age groups. Immunoglobulin (Ig)A vasculitis and Kawasaki disease usually present in children whereas giant cell arteritis (GCA) and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis usually present in the middle aged/elderly. In Northern Europe, granulomatosis with polyangiitis (GPA; Wegener's) is commoner than microscopic polyangiitis (MPA) and MPA is more common than eosinophilic granulomatosis with polyangiitis (EPGA; Churg-Strauss syndrome). In Southern Europe, MPA is commoner than GPA and in Japan MPA is much more common than GPA. Major differences exist worldwide in ANCA specificity which are not entirely related to different phenotypes. GPA, like GCA, has a cyclical pattern of onset suggesting possible infection as an aetiological agent. International studies have given important clues to possible aetiology including silica dust and infection and genetic influences, as shown by the recently published genome-wide association study which revealed that single-nucleotide polymorphisms associate more strongly with ANCA than clinical syndromes. A brief description of the main clinical features of ANCA-associated vasculitis is also given.

Entities:  

Mesh:

Year:  2013        PMID: 23843034     DOI: 10.1007/s10157-013-0830-8

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.617


  13 in total

1.  Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease.

Authors:  Ann Knight; Sven Sandin; Johan Askling
Journal:  Arthritis Rheum       Date:  2008-01

2.  Classification and epidemiology of systemic vasculitis.

Authors:  D G Scott; R A Watts
Journal:  Br J Rheumatol       Date:  1994-10

3.  ANCA vasculitis: to lump or split? Why we should study MPA and GPA separately.

Authors:  Richard A Watts; David G I Scott
Journal:  Rheumatology (Oxford)       Date:  2012-08-25       Impact factor: 7.580

Review 4.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

5.  Significantly high regional morbidity of MPO-ANCA-related angitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan).

Authors:  M Yashiro; E Muso; T Itoh-Ihara; A Oyama; K Hashimoto; T Kawamura; T Ono; S Sasayama
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

6.  Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.

Authors:  Shouichi Fujimoto; Richard A Watts; Shigeto Kobayashi; Kazuo Suzuki; David R W Jayne; David G I Scott; Hiroshi Hashimoto; Hiroyuki Nunoi
Journal:  Rheumatology (Oxford)       Date:  2011-07-28       Impact factor: 7.580

7.  The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis.

Authors:  Richard A Watts; Janice Mooney; Jane Skinner; David G I Scott; Alex J Macgregor
Journal:  Rheumatology (Oxford)       Date:  2012-01-17       Impact factor: 7.580

8.  Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate.

Authors:  Alfred Mahr; Loïc Guillevin; Marc Poissonnet; Ségolène Aymé
Journal:  Arthritis Rheum       Date:  2004-02-15

9.  Are environmental factors important in primary systemic vasculitis? A case-control study.

Authors:  Suzanne E Lane; Richard A Watts; Graham Bentham; Nicholas J Innes; David G I Scott
Journal:  Arthritis Rheum       Date:  2003-03

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
View more
  27 in total

1.  Two cases of atypical hemolytic uremic syndrome (aHUS) and eosinophilic granulomatosis with polyangiitis (EGPA): a possible relationship.

Authors:  Mercedes Cao; Tamara Ferreiro; Bruna N Leite; Francisco Pita; Luis Bolaños; Francisco Valdés; Angel Alonso; Eduardo Vázquez; Juan Mosquera; María Trigás; Santiago Rodríguez
Journal:  CEN Case Rep       Date:  2017-03-01

Review 2.  ANCA Glomerulonephritis and Vasculitis.

Authors:  J Charles Jennette; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-25       Impact factor: 8.237

Review 3.  An update on the role of epigenetics in systemic vasculitis.

Authors:  Patrick Coit; Haner Direskeneli; Amr H Sawalha
Journal:  Curr Opin Rheumatol       Date:  2018-01       Impact factor: 5.006

4.  Anti-neutrophil cytoplasmic antibody-negative microscopic polyangiitis: A case report and literature review.

Authors:  Ran Wang; Xiao-Chun Yang; Si-Jing Zhou; Geng-Yun Sun
Journal:  Exp Ther Med       Date:  2015-05-26       Impact factor: 2.447

5.  Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases.

Authors:  Antoine G Sreih; Narender Annapureddy; Jason Springer; George Casey; Kevin Byram; Andy Cruz; Maya Estephan; Vince Frangiosa; Michael D George; Mei Liu; Adam Parker; Sapna Sangani; Rebecca Sharim; Peter A Merkel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-11-01       Impact factor: 2.890

Review 6.  B cell-mediated pathogenesis of ANCA-mediated vasculitis.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

Review 7.  Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.

Authors:  Marc Hilhorst; Pieter van Paassen; Jan Willem Cohen Tervaert
Journal:  J Am Soc Nephrol       Date:  2015-05-08       Impact factor: 10.121

8.  Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies.

Authors:  Weifeng Shang; Yong Ning; Xiu Xu; Menglan Li; Shuiming Guo; Min Han; Rui Zeng; Shuwang Ge; Gang Xu
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

Review 9.  Treatment Updates in Antineutrophil Cytoplasmic Autoantibodies (ANCA) Vasculitis.

Authors:  Koyal Jain; Pankaj Jawa; Vimal K Derebail; Ronald J Falk
Journal:  Kidney360       Date:  2021-04-29

Review 10.  Pediatric Vasculitis.

Authors:  Davinder Singh-Grewal; Anne Maria Durkan
Journal:  Indian J Pediatr       Date:  2015-09-14       Impact factor: 5.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.